Stereoselective binding of propranolol enantiomers to human alpha 1‐ acid glycoprotein and human plasma.

F. Albani, R. Riva, M. Contin, A. Baruzzi

Research output: Contribution to journalArticle

Abstract

The binding of propranolol enantiomers to human albumin (ALB), alpha 1‐ acid glycoprotein (alpha 1‐AGP) and plasma was studied. (‐) propranolol is more bound than (+)propranolol to alpha 1‐AGP (P less than 0.001) and to plasma (P less than 0.05). In solutions containing ALB at a constant concentration (580 mumol/l) and alpha 1‐AGP at increasing concentrations, the binding of both isomers increases but the stereo selectivity is evident throughout the alpha 1‐AGP concentration range examined (25‐100 mumol/l). 1984 The British Pharmacological Society

Original languageEnglish
Pages (from-to)244-246
Number of pages3
JournalBritish Journal of Clinical Pharmacology
Volume18
Issue number2
DOIs
Publication statusPublished - 1984

Fingerprint

Orosomucoid
Propranolol
Albumins

ASJC Scopus subject areas

  • Pharmacology (medical)
  • Pharmacology
  • Pharmacology, Toxicology and Pharmaceutics(all)

Cite this

Stereoselective binding of propranolol enantiomers to human alpha 1‐ acid glycoprotein and human plasma. / Albani, F.; Riva, R.; Contin, M.; Baruzzi, A.

In: British Journal of Clinical Pharmacology, Vol. 18, No. 2, 1984, p. 244-246.

Research output: Contribution to journalArticle

@article{2ec30efc9e764df994008f9b77759517,
title = "Stereoselective binding of propranolol enantiomers to human alpha 1‐ acid glycoprotein and human plasma.",
abstract = "The binding of propranolol enantiomers to human albumin (ALB), alpha 1‐ acid glycoprotein (alpha 1‐AGP) and plasma was studied. (‐) propranolol is more bound than (+)propranolol to alpha 1‐AGP (P less than 0.001) and to plasma (P less than 0.05). In solutions containing ALB at a constant concentration (580 mumol/l) and alpha 1‐AGP at increasing concentrations, the binding of both isomers increases but the stereo selectivity is evident throughout the alpha 1‐AGP concentration range examined (25‐100 mumol/l). 1984 The British Pharmacological Society",
author = "F. Albani and R. Riva and M. Contin and A. Baruzzi",
year = "1984",
doi = "10.1111/j.1365-2125.1984.tb02462.x",
language = "English",
volume = "18",
pages = "244--246",
journal = "British Journal of Clinical Pharmacology",
issn = "0306-5251",
publisher = "Wiley-Blackwell",
number = "2",

}

TY - JOUR

T1 - Stereoselective binding of propranolol enantiomers to human alpha 1‐ acid glycoprotein and human plasma.

AU - Albani, F.

AU - Riva, R.

AU - Contin, M.

AU - Baruzzi, A.

PY - 1984

Y1 - 1984

N2 - The binding of propranolol enantiomers to human albumin (ALB), alpha 1‐ acid glycoprotein (alpha 1‐AGP) and plasma was studied. (‐) propranolol is more bound than (+)propranolol to alpha 1‐AGP (P less than 0.001) and to plasma (P less than 0.05). In solutions containing ALB at a constant concentration (580 mumol/l) and alpha 1‐AGP at increasing concentrations, the binding of both isomers increases but the stereo selectivity is evident throughout the alpha 1‐AGP concentration range examined (25‐100 mumol/l). 1984 The British Pharmacological Society

AB - The binding of propranolol enantiomers to human albumin (ALB), alpha 1‐ acid glycoprotein (alpha 1‐AGP) and plasma was studied. (‐) propranolol is more bound than (+)propranolol to alpha 1‐AGP (P less than 0.001) and to plasma (P less than 0.05). In solutions containing ALB at a constant concentration (580 mumol/l) and alpha 1‐AGP at increasing concentrations, the binding of both isomers increases but the stereo selectivity is evident throughout the alpha 1‐AGP concentration range examined (25‐100 mumol/l). 1984 The British Pharmacological Society

UR - http://www.scopus.com/inward/record.url?scp=0021220079&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0021220079&partnerID=8YFLogxK

U2 - 10.1111/j.1365-2125.1984.tb02462.x

DO - 10.1111/j.1365-2125.1984.tb02462.x

M3 - Article

C2 - 6487464

AN - SCOPUS:0021220079

VL - 18

SP - 244

EP - 246

JO - British Journal of Clinical Pharmacology

JF - British Journal of Clinical Pharmacology

SN - 0306-5251

IS - 2

ER -